LLY is trading at $977.58 (+3.07%) as bearish pressure from the recent Foundayo launch eases, allowing the stock to stage a modest rebound from Friday's sell-off.
- The stock is recovering from a 2.72% decline on Friday, which saw shares close at $948.45 following reports of weak prescription numbers (3,707 for Foundayo vs. 18,410 for Wegovy).
- The gain aligns with a broader market uptick as the S&P 500 rose +0.18% in a quiet session lacking significant economic catalysts or new company-specific developments.